Dormant Company Accounts - ONE MEDICAL TECHNOLOGIES LIMITED

Dormant Company Accounts - ONE MEDICAL TECHNOLOGIES LIMITED


Companies House true 2021-06-01 2022-05-31 false 11369647 uk-bus:Director1 2021-06-01 2022-05-31 11369647 uk-bus:Director2 2021-06-01 2022-05-31 11369647 2021-06-01 2022-05-31 11369647 2022-05-31 11369647 uk-bus:EntityHasNeverTraded 2021-06-01 2022-05-31 11369647 uk-bus:FRS102 2021-06-01 2022-05-31 11369647 uk-bus:FullAccounts 2021-06-01 2022-05-31 11369647 uk-bus:AuditExempt-NoAccountantsReport 2021-06-01 2022-05-31 11369647 2021-05-31 11369647 uk-bus:OrdinaryShareClass1 2021-06-01 2022-05-31 11369647 uk-bus:OrdinaryShareClass2 2021-06-01 2022-05-31 11369647 uk-bus:OrdinaryShareClass3 2021-06-01 2022-05-31 11369647 uk-bus:PreferenceShareClass1 2021-06-01 2022-05-31 11369647 uk-bus:PreferenceShareClass2 2021-06-01 2022-05-31 11369647 uk-bus:PreferenceShareClass3 2021-06-01 2022-05-31 11369647 uk-core:ShareCapitalPreferenceShares 2022-05-31 11369647 uk-core:ShareCapitalPreferenceShares 2021-05-31 iso4217:GBP xbrli:shares

Registered Number 11369647

ONE MEDICAL TECHNOLOGIES LIMITED

Dormant Accounts

31 May 2022

ONE MEDICAL TECHNOLOGIES LIMITED Registered Number 11369647

Balance Sheet as at 31 May 2022

2022 2021
£ £
Current assets
Cash at bank and in hand
1
1
Net assets
1
1
Issued share capital
1 Ordinary Share of £ 1 each 1 1
Total Shareholder funds
1
1

STATEMENTS

  1. For the year ending 31 May 2022 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 9 June 2022

And signed on their behalf by:
SUSAN GALE, Director